News
HOME  keyboard_arrow_right  News  keyboard_arrow_right  News  keyboard_arrow_right  FUKUSHIMA (GALILEI) recognized internationally again
News
2020/11/12
FUKUSHIMA (GALILEI) recognized internationally again

The US pharmaceutical company Pfizer and the German biotechnology company BioNTech have developed a COVID-19 candidate vaccine, which brings hope to solve the global epidemic, but the vaccine needs to be delivered at -70 degrees. Under the large demand for vaccines, Japan's Fukushima Galilei stock price rose intraday the highest in more than two years.

 

Japan's FUKUSHIMA (GALILEI) has been deeply plowing the cold storage/freezing preservation technology for more than ten years. As a leading brand of cold storage/freezer refrigerators, we continue to improve temperature control technology and provide a series of high-precision temperature control technology for medical and laboratory medicinal refrigerators and incubators.

 

FUKUSHIMA (GALILEI) MediFridge medicinal freezing and refrigerating refrigerators are controlled by high-precision microcomputers and equipped with a complete alarm system to ensure that vaccines, medicines, reagents, blood samples, etc. are stored in the best conditions. At the same time, the product of the same specification also provides relatively preferential prices, so that you can create the best quality storage environment without high costs.

 

 

Refer to:https://ec.ltn.com.tw/article/breakingnews/3348833